In addition, the activation and remodulation of these Ti-DCs by MIP leads to significant upregulation in the expression of IL-12 and IL-6 on these cells, both of which are key players for inducing acute inflammation to confer protective anti-tumor immunity (Figure 3D). The gene discussed is MIP; the disease is neoplasm.